67 yr Caucasian male with ESRD due to Ig A nephropathy, on dialysis since July 2016, DVT left leg with pulmonary embolism in 2004, Factor V Leiden heterozygous mutation(diagnosed in 2004: on coumadin) and HTN presented in early Sep 2016 with thrombosed right upper extremity loop AVG. Thrombectomy was performed successfully. Venous anastomotic stenosis was the culprit lesion. He presented again 2 weeks later with thrombosis of the AVG. Successful thrombectomy was performed. This time, there was no significant stenotic lesion in the access. INR was between 2-3 at all visits. BP log at HD unit did not reveal hypotension episodes.
My questions are:
1) Is the recurrent AVG thrombosis due to Factor V Leiden mutation?
2) If he comes again with AVG thrombosis, would you place a catheter?
3) Should coumadin be switched to Eliquis since the risk of major bleeding with coumadin in ESRD patients is high?
Posted Monday, October 24, 2016
Firstly, I would suggest that if you have not stented the VA, this lesion is still the likely culprit. Also, complete arteriogram may be needed to evaluate for adequate arterial inflow. Also, I would make certain the arterial anastomosis is nicely patent. Sometimes, this connection needs to be dilated without an obvious lesion on angiography. The stenosis can be difficult to see with fluoroscopy, but it will almost always be apparent on an angioplasty balloon.
Secondly, does this patient have adequate cardiac reserve. If he has systolic dysfunction, he may not be able to support the blood flow through the graft. If you can assess blood flow volumes through the graft, this might assist in assessing the arterial inflow when the graft is fully patent.
Thirdly, there is no good data on anticoagulation and graft thrombosis. There have been some suggestions that clopidogrel may be helpful, but this was really a trend and has not been rigorously studied. There is similar weak data for Aggrenox.